Regulatory Science and Policy Events

Receive updates about upcoming Regulatory and Science Policy Workshops, including information about workshop registration. You can also stay up-to-date on policy issues affecting cancer research by reading and subscribing to our Cancer Policy Monitor.

upcoming event

FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases (May 9, 2024)

RECENT events

FDA-AACR Public Workshop: Optimizing Dosages for Oncology Drug Products (February 15-16, 2024)

FDA-AACR-ASA Workshop: Overall Survival in Oncology Clinical Trials (July 18, 2023)

Regulatory Science and Policy Track at the AACR Annual Meeting 2023 (April 14-19, 2023)

---

Past Events

• Regulatory Science and Policy Track at the AACR Annual Meeting 2022 (April 8-13, 2022)
• Regulatory Science and Policy Track at the AACR Virtual Annual Meeting (May 17-21, 2021)
• Regulatory Science and Policy Track at the AACR Virtual Annual Meeting (June 22-24, 2020)
• NIH-AACR Cancer, Autoimmunity, and Immunology Conference 2020 (March 23-24, 2020)
• FDA-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Therapeutic Trials (February 28, 2020)
• FDA-AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials (February 13, 2020)
• FDA-AACR Real-world Evidence Workshop (July 19, 2019)
• NIH-AACR Cancer, Autoimmunity, and Immunology Conference (April 15-16, 2019)
• (March 29-April 3, 2019)
• FDA-AACR Non-clinical Models for Safety Assessment of Immuno-oncology Products Workshop (September 6, 2018)
• FDA-AACR-SGO Drug Development for Gynecological Malignancies Workshop (June 14, 2018)
• Regulatory Science and Policy Track at the AACR Annual Meeting 2018 (April 14-18, 2018)
• FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations Workshop (February 22-23, 2018)
• FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Workshop Part II (October 10, 2017)
• FDA-AACR Oncology Dose-finding Workshop Part III (July 20, 2017)
• Regulatory Science and Policy Track at the AACR Annual Meeting 2017 (April 1-4, 2017)
• FDA-AACR Immuno-oncology Drug Development Workshop (October 13-14, 2016)
• FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Workshop Part I
• (July 19, 2016)
• FDA-AACR Oncology Dose-finding Workshop Part II (June 13, 2016)
• Regulatory Science and Policy Track at AACR Annual Meeting 2016 (April 16-20, 2016)
• Ovarian Cancer Endpoints Workshop (September 3, 2015)
• Dose-finding of Small Molecule Oncology Drugs Workshop Part I (May 18-19, 2015)
• Regulatory Science and Policy Track at AACR Annual Meeting 2015 (April 18-22, 2015)
• Complexities in Personalized Medicine: Harmonizing Companion Diagnostics Across a Class of Targeted Therapies (March 24, 2015)
• Regulatory Science and Policy Track at AACR Annual Meeting 2014 (April 5-9, 2014)
• FDA-AACR-ASCO-BCRF Innovations in Breast Cancer Drug Development- Next Generation Oncology Trials Workshop (October 21, 2014)
• AACR-AdvaMedDx Cancer Diagnostics Symposium: Transforming Cancer Care through Diagnostics and Personalized Medicine (October 29, 2013)
• AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Combining Immunotherapies, Immune Modulators, and Targeted Therapies: Regulatory Opportunities Challenges (October 23, 2013)
• Regulatory Science and Policy Track at AACR Annual Meeting 2013 (April 6-10, 2013)
• Regulatory Science and Policy Track at AACR Annual Meeting 2012 (March 31- April 4, 2012)